We have compared the levels of creatine kinase (CK) activity and the distribution of CK isoenzymes determined by agarose gel electrophoresis in normal colon, liver and lung tissues, and in colon, liver and lung adenocarcinomas, lung squamous cell carcinomas and lung carcinoids. Colon and lung adenocarcinomas, and squamous cell carcinomas presented lower CK activity than the normal tissues and no differences were found between hepatocarcinoma and normal liver tissue. In contrast, lung carcinoids had higher CK activity than normal lung tissue. Type BB-CK was the predominant isoenzyme in normal lung, colon and liver tissues. Type MM isoenzyme was detected in normal lung and type MB-CK was found in normal colon. In most lung tumours the CK isoenzyme electrophoretic pattern did not change. However, no type BB-CK was detected in some hepatocarcinomas, type MM-CK decreased in lung carcinoids and type MB isoenzyme was not observed in colon adenocarcinomas. It is concluded that in most tumours there is a decrease in the expression of type B-and type M-CK subunits, whereas in lung carcinoid the expression of type B-CK activity increases. Thus, the increase in type BB-CK observed in the serum of patients with lung and colon adenocarcinomas is probably due mainly to enhanced enzyme release as a result of tumour cell necrosis.
Creatine kinase (ATP:creatine N-phosphotransferase, EC 2.7.3.2, CK) is a ubiquitous enzyme that catalyses the reversible transphosphorylation reaction between ATP and creatine, generating ADP and phosphocreatine (for a review see Bessman and Carpenter, 1985) . In mammalian tissues four CK subunits are expressed, encoded by different genes: two cytosolic subunits (M-CK and B-CK) and two mitochondrial (Mt-CK) subunits, 'ubiquitous' Mt-CK (uMt-CK) and 'sarcomeric' Mt-CK (sMt-CK). In vivo, M-CK and B-CK subunits combine to give three dimeric cytosolic CK isoenzymes: type MM-, MB-, and BB-CK. MM-CK is rather specific for differentiated striated muscle (Burger et al., 1963) and mature spermatozoa (Huszar and Vigue, 1990) . BB-CK is found in most adult tissues as well as in embryonic skeletal and cardiac muscle. MB-CK is detected in adult mammalian heart and in straited muscle during the developmental transition. The Mt-CK subunit forms octameric and dimeric molecules located within the mitochondrial intermembrane space (for review see Foreback and Chu, 1981; Wallimann et al, 1992; Wyss et al, 1992) .
The present study was undertaken to determine the distribution of the total CK activity and isoenzymes in lung, colon and liver carcinomas as a first step to study the alterations of the expression of creatine kinase isoenzymes in neoplastic cells. Many reports have been published on the distribution of CK subunits and isoenzymes in tumours (for review see Foreback and Chu, 1981; Bais and Edwards, 1982; Griffiths, 1982; Nanji, 1983; Kanemitsu and Okigaki, 1988) . However, most data have been obtained by immunohistochemical and immunoassay techniques.
MATERIALS AND METHODS Materials
Enzymes, substrates, co-factors and biochemicals were purchased from either Boehringer (Mannheim, Germany) or Sigma (St Louis, MI, USA). CK-MB DS reaction mixture (cat. no. 1.12948) from Merck (Darmstadt, Germany) was used as source of M-CK antibodies. P-Mercaptoethanol was from Merck and bovine serum albumin was from Calbiochem (La Jolla, CA, USA). Other chemicals were reagent grade. Agar noble was obtained from Difco Laboratories (Detroit, MI, USA) and agarose gels were from CibaComing (Palo Alto, CA, USA). Tissue extracts were prepared by homogenization in three volumes (w/v) of cold Tris-buffer (20 mm Tris, 1 mM EDTA, 1 mM 3-mercaptoethanol, pH 7.5) with a Polytron homogenizer (Lucerne, Switzerland) (position 5, 20 s). Cellular debris were removed by 
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RESULTS
Distribution of CK activity in lung, colon and liver normal tissues and tumours Extracts of colon and lung adenocarcinomas possess lower CK activity than the corresponding normal tissues (P < 0.05). Lung squamous cell carcinomas tend also to have lower CK activity than normal lung tissue, although the differences observed are not statistically significant. In contrast, the extracts of two carcinoids of the lung possess much higher CK levels than the extracts of the corresponding normal tissue. No differences have been found between hepatocarcinomas and normal liver tissue.
Distribution of CK isoenzymes in lung normal tissue and tumours Figure 1 shows some of the electrophoretograms of lung tumours and of the corresponding normal tissues determined by agarose gel electrophoresis.
In all 14 normal specimens studied by us, one anodic band was detected, corresponding to type BB-CK, and one or two very thin cathodic bands that migrate in a similar manner to the dimeric and octameric forms of Mt-CK (lanes 7, 9, 11 and 13) was defected. In four samples we observed an additional band in a position equivalent to that of type MM-CK (lanes 3 and 5), but type MB-CK was not detected in any specimens.
In a control experiment (not shown), no band was visualized when phosphocreatine was omitted from the staining mixture, which proved that the bands were not adenylate kinase. As shown in Figure 2 , the band migrating as type MM-CK was not detected after incubation of lung extract with anti-M-CK antibodies. In contrast, the cathodic bands migrating as Mt-CK were not affected by this treatment. Thus, we conclude that BB-CK is the main CKcytosolic isoenzyme present in normal human lung tissue, although MM-CK can be also detected.
We found that the CK isoenzyme electrophoretic pattems of extracts of adenocarcinomas ( Figure 1, lanes 2, 6, and 12 ) and of squamous cell carcinomas of the lung (Figure 1, lanes 4, 8 and 10 ) did not present qualitative differences compared with extracts of the corresponding normal tissues. In contrast, in two carcinoids of the lung, we observed a change in the normal CK electrophoretic pattem. Only the band of type BB-CK was detected in the extracts of the carcinoids (Figure 1, lanes 14 and 16) , whereas an additional cathodic band migrating as Mt-CK was observed in the corresponding normal tissues.
Distribution of CK isoenzymes in colon normal tissue and tumours
In all extracts of normal colon (Figure 3, lanes 3, 5 and 7) , we observed the presence of BB-CK and of two cathodic bands migrating as the dimeric and octameric forms of Mt-CK. In addition, an anodic band in a position corresponding to that of MB-CK was observed in three out of ten specimens (lanes 3 and 5). As shown in Figure 2 (lane 6), the band migrating as MB-CK was undetectable after incubation of the extract with anti-M-CK antibodies, whereas the two cathodic bands were not affected by this treatment. BB-CK was predominant in all specimens. The proportion of Mt-CK with respect to the total CK activity could not be quantified from the electrophoretograms, as in order to detect the Mt-CK bands it was necessary to apply large volumes of the extracts, over the limit of proportionality of the staining method.
As in the normal tissue, in colon adenocarcinomas (Figure 3 lanes 2, 4 and 6) BB-CK was the predominant CK isoenzyme. However, the band of MB-CK detected in some normal specimens was not present in tumoral tissue, which shows a decrease in the expression of type M-CK subunit. 
Distribution of CK isoenzymes in liver normal tissue and tumours
As shown in Figure 3 (lanes 11, 13 and 15 ), we detected in six extracts of normal liver the band corresponding to BB-CK and two cathodic bands corresponding to Mt-CK. In addition, we detected a faint band slightly ahead of MM-CK, which in a control experiment (not shown) was proved to correspond to adenylate kinase not inhibited by the AMP present in the staining mixture. It is known that liver adenylate kinase is more resistant to inhibition A BB MB MM Mt than the other adenylate kinase isoenzymes (Hamada et al, 1987; Schulz et al, 1987) . No MM-CK was detected in any specimen.
Most of the extracts of hepatocarcinomas analysed by us showed the same CK electrophoretic pattern as that of normal liver tissue. However, BB-CK was not detected in two of them ( Figure  3, lane 14) . Figure 3 Electrophoretograms of CK isoenzymes in extracts of human liver and colon normal tissues and tumours. Colon specimens are shown in A: lanes 2, 4 and 6, adenocarcinomas; lanes 3, 5 and 7, normal tissues. Liver specimens are shown in B: lanes 10, 12 and 14, hepatocarcinomas; lanes 11, 13 and 15, normal tissues. Lanes 1 and 9, human heart extracts. Lanes 8 and 16, human brain extracts (cortex) DISCUSSION Our data show that colon and lung adenocarcinomas and squamous cell carcinomas of the lung possess lower CK activity than the corresponding normal tissues. In contrast, lung carcinoids have higher CK levels and no difference exists between CK levels in hepatocarcinomas and in normal liver tissue. These results agree with other published results on colon carcinomas (Tsung, 1982b (Tsung, , 1983 and lung carcinomas (Coolen et al, 1979; Gazdar et al, 1981; Tsung, 1983) . Most data obtained by immunological techniques (Wretou and Pfleiderer, 1975; Usui et al, 1987) , ion-exchange chromatography (Roberts et al, 1975; Tsung 1976 Tsung , 1983 Vergnon, 1983) and electrophoresis (Allard and Cabrol, 1970; Smith, 1972; Coolen et al, 1979) have shown that in normal lung BB-CK is the predominant isoenzyme. MM-CK is found in a much lower proportion and MB-CK is present at very low levels. Only one report (Roberts et al, 1975 ) detected higher levels of MM-CK than of BB-CK. Our results confirm that BB-CK is the major CK cytosolic isoenzyme in normal lung tissue, although MM-CK is also present at much lower levels. The absence of MB-CK in extracts that possess MM-and BB-CK suggests that type M-and type B-CK subunits are expressed in different lung cell types.
Using immunological techniques, some authors (Wold et al, 1981; Gosney et al, 1994) found lower expression of BB-CK in small-cell lung carcinomas than in other lung carcinomas. However, other authors (Gazdar et al, 1981; Carney et al, 1984; Usui et al, 1987) have reported that the levels of BB-CK in smallcell lung carcinomas are much greater than those of normal lung, and that the BB-CK levels in non-small-cell lung carcinomas are lower than those of normal lung (Gazdar et al, 1981; Usui et al, 1987) . In all types of lung carcinoma (except one case of small-cell carcinoma), MB-CK and MM-CK levels were found by Usui et al (1987) to be low and similar to those of normal lung. Using ionexchange chromatography (Tsung, 1983) and by electrophoretic analysis (Coolen et al, 1979; De Luca et al, 1981; Gazdar et al, 1981; Tsung, 1983; Lee et al, 1985; McGing et al, 1988) , it has also been found that BB-CK is the predominant CK isoenzyme in several types of lung carcinoma. Our results show that, whereas lung adenocarcinomas and squamous cell carcinomas possess BBand MM-CK isoenzymes in a proportion similar to those of the normal lung tissue, the proportion of BB-CK increases in carcinoids of the lung.
It has been shown by electrophoresis (Griffiths, 1982; Tsung, 1982a Tsung, , 1982b Tsung, , 1983 Urdal et al, 1983; Chastain et al, 1988) , ionexchange chromatography (Tsung, 1976 (Tsung, , 1982a (Tsung, , 1982b (Tsung, , 1983 and immunoinhibition (Chastain et al, 1988 ) that human colon possesses mainly type BB-CK. BB-CK has been found to be predominant also in colon adenocarcinomas (Coolen et al, 1979; Tsung 1982b Tsung , 1983 . However, Graeber et al (1981) reported significant amounts of MM-CK and MB-CK in normal colon, and Tsung (1982b Tsung ( , 1983 indicated that colon malignant tissue had a higher proportion of MM-CK than normal tissue. The conflicting results can be explained by the confusion created by Mt-CK and BB-CK. Mt-CK, which is more abundant in colon tumours than in normal colon tissue (Okano et al, 1987; McGing et al, 1988) , can contaminate the MM-CK band. Post-mortem changes in BB-CK can produce a band with an electrophoretic mobility similar to that of MB-CK (Chastain et al, 1988) . Our results show that BB-CK is the major CK isoenzyme in normal colon tissue and in colon adenocarcinoma, and that MB-CK, which is found in low proportion in normal tissue, is not detectable in colon tumours.
The distribution of CK isoenzymes in human liver has been determined by immunotitration (Wretou and Pfleiderer, 1975) , ion-exchange chromatography (Roberts et al, 1975; Wretou and Pfleiderer, 1975; Tsung, 1976 Tsung, , 1983 and electrophoresis (Allard and Cabrol, 1970; Smith, 1972; Griffiths, 1982; Tsung, 1983) . Some studies have reported only type BB-CK, but others have detected predominantly MM-CK. In two human liver tumours carried in athymic mice, DeLuca et al (1981) showed a high proportion of BB-CK and a low concentration of MM-CK and Mt-CK. The discrepancies probably result from confusion created by Mt-CK. Liver mitochondrial extracts have two cathodic Mt-CK forms that can be converted into a new form at the MM-CK position after long-term storage (Kanemitsu, 1982a (Kanemitsu, , 1982b (Kanemitsu, , 1983 . Moreover, liver Mt-CK is readily released (Urdal et al, 1983) . Our results confirm that BB-CK is the predominant CK isoenzyme in both normal liver tissue and hepatocarcinoma, although two of six tumours presented a large decrease in BB-CK levels.
In summary, the results herein presented demonstrate that, in contrast to phosphoglycerate mutase and enolase activities (Durany et al, 1997) , CK activity does not increase in most lung, colon and liver carcinomas. One exception is the carcinoid of the lung which, as has been reported to occur in small-cell lung carcinoma, presents higher CK activity than the normal tissue. The results also show that in most tumours there is a decrease in the expression of type M-CK subunit that is present at very low levels in normal lung, and colon tissues.
Normal human serum contains MM-CK almost exclusively and it has been suggested that serum BB-CK could be used as a tumour marker (Foreback and Chu, 1981; Bais and Edwards, 1982; Grifflths, 1982; Nanji, 1983; Kanemitsu and Okigaki, 1988) . Serum BB-CK increases in patients with small-cell lung carcinoma, which has higher BB-CK levels than the normal lung tissue. But serum BB-CK has also been found increased in patients with squamous cell carcinoma and adenocarcinoma of the lung and in patients with late-stage colon adenocarcinoma (Hoag et al, 1978; Coolen et al, 1979; Bumam et al, 1981; Griffiths, 1982; Mercer and Talamo, 1985; Usui et al, 1987; Arenas et al, 1989) . As these tumours have lower BB-CK levels than the normal tissues, we conclude that the increase observed in serum BB-CK levels is probably mainly due to enhanced enzyme release from tumour cell necrosis.
